| Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy RK Nam, R Saskin, Y Lee, Y Liu, C Law, LH Klotz, DA Loblaw, ... The Journal of urology 183 (3), 963-969, 2010 | 794 | 2010 |
| Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer MA Haider, TH Van Der Kwast, J Tanguay, AJ Evans, AT Hashmi, ... American journal of roentgenology 189 (2), 323-328, 2007 | 730 | 2007 |
| Screening for prostate cancer: a decision analytic view MD Krahn, JE Mahoney, MH Eckman, J Trachtenberg, SG Pauker, ... Jama 272 (10), 773-780, 1994 | 529 | 1994 |
| Prostate cancer detection with multi‐parametric MRI: logistic regression analysis of quantitative T2, diffusion‐weighted imaging, and dynamic contrast‐enhanced MRI DL Langer, TH Van der Kwast, AJ Evans, J Trachtenberg, BC Wilson, ... Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2009 | 447 | 2009 |
| The role of focal therapy in the management of localised prostate cancer: a systematic review M Valerio, HU Ahmed, M Emberton, N Lawrentschuk, M Lazzeri, ... European urology 66 (4), 732-751, 2014 | 424 | 2014 |
| Effect of total-body prehabilitation on postoperative outcomes: a systematic review and meta-analysis D Santa Mina, H Clarke, P Ritvo, YW Leung, AG Matthew, J Katz, ... Physiotherapy 100 (3), 196-207, 2014 | 422 | 2014 |
| Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities SE Eggener, PT Scardino, PR Carroll, MJ Zelefsky, O Sartor, H Hricak, ... The Journal of urology 178 (6), 2260-2267, 2007 | 408 | 2007 |
| Expression of the TMPRSS2: ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer RK Nam, L Sugar, W Yang, S Srivastava, LH Klotz, LY Yang, ... British journal of cancer 97 (12), 1690-1695, 2007 | 329 | 2007 |
| Prostate Tissue Composition and MR Measurements: Investigating the Relationships between ADC, T2, Ktrans, ve, and Corresponding Histologic Features DL Langer, TH van der Kwast, AJ Evans, A Plotkin, J Trachtenberg, ... Radiology 255 (2), 485-494, 2010 | 312 | 2010 |
| Image guided photothermal focal therapy for localized prostate cancer: phase I trial U Lindner, RA Weersink, MA Haider, MR Gertner, SRH Davidson, M Atri, ... The Journal of urology 182 (4), 1371-1377, 2009 | 298 | 2009 |
| Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy MA Haider, P Chung, J Sweet, A Toi, K Jhaveri, C Ménard, P Warde, ... International Journal of Radiation Oncology* Biology* Physics 70 (2), 425-430, 2008 | 298 | 2008 |
| The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy RA Rendon, JR Kachura, JM Sweet, MR Gertner, MD Sherar, M Robinette, ... The Journal of urology 167 (4), 1587-1592, 2002 | 279 | 2002 |
| Intermixed Normal Tissue within Prostate Cancer: Effect on MR Imaging Measurements of Apparent Diffusion Coefficient and T2—Sparse versus Dense Cancers1 DL Langer, TH van der Kwast, AJ Evans, L Sun, MJ Yaffe, J Trachtenberg, ... Radiology 249 (3), 900-908, 2008 | 278 | 2008 |
| Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities RA Weersink, A Bogaards, M Gertner, SRH Davidson, K Zhang, ... Journal of Photochemistry and Photobiology B: Biology 79 (3), 211-222, 2005 | 254 | 2005 |
| Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of … J Trachtenberg, A Bogaards, RA Weersink, MA Haider, A Evans, ... The Journal of urology 178 (5), 1974-1979, 2007 | 228 | 2007 |
| ‘Prostatic evasive anterior tumours’: the role of magnetic resonance imaging N Lawrentschuk, MA Haider, N Daljeet, A Evans, A Toi, A Finelli, ... BJU international 105 (9), 1231-1236, 2010 | 226 | 2010 |
| A phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer Abarelix Study Group, J Trachtenberg, M Gittleman, C Steidle, W Barzell, ... The Journal of urology 167 (4), 1670-1674, 2002 | 225 | 2002 |
| Correlation of prostatic nuclear androgen receptor content with duration of response and survival following hormonal therapy in advanced prostatic cancer J Trachtenberg, PC Walsh The Journal of Urology 127 (3), 466-471, 1982 | 223 | 1982 |
| Focal therapy in prostate cancer—report from a consensus panel J De la Rosette, H Ahmed, J Barentsz, TB Johansen, M Brausi, ... Journal of Endourology 24 (5), 775-780, 2010 | 210 | 2010 |
| Vascular‐targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses J Trachtenberg, RA Weersink, SRH Davidson, MA Haider, A Bogaards, ... BJU international 102 (5), 556-562, 2008 | 209 | 2008 |
